Fundraising FoxHyrax Biosciences (Pty) Ltd
1 known investors
Find your way into Hyrax Biosciences (Pty) Ltd
Sign up to find every way you can get introduced to Hyrax Biosciences (Pty) Ltd
- Your email: who you already know at Hyrax Biosciences (Pty) Ltd, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Hyrax Biosciences (Pty) Ltd team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Hyrax Biosciences develops Exatype, a DNA sequence analysis software platform that performs genotyping, quality control, reference mapping, and mutation calling for pathogens including HIV, TB, SARS-CoV-2, and cancer. It serves assay and instrument manufacturers, laboratories, pharmaceutical companies, clinical trial organizations, and research institutions.
Investors · 1
Frequently asked questions
- What does Hyrax Biosciences (Pty) Ltd do?
- Hyrax Biosciences develops Exatype, a DNA sequence analysis software platform that performs genotyping, quality control, reference mapping, and mutation calling for pathogens including HIV, TB, SARS-CoV-2, and cancer. It serves assay and instrument manufacturers, laboratories, pharmaceutical companies, clinical trial organizations, and research institutions.
- Who are Hyrax Biosciences (Pty) Ltd's investors?
- Hyrax Biosciences (Pty) Ltd's investors include Asia Africa Investment & Consulting (AAIC).